Mandatory Guidelines for Federal Workplace Drug Testing Programs, 74063-74064 [2011-30846]
Download as PDF
<![CDATA[
74063
Federal Register / Vol. 76, No. 230 / Wednesday, November 30, 2011 / Notices
TABLE 1—FEDERAL MEDICAL ASSISTANCE PERCENTAGES AND ENHANCED FEDERAL MEDICAL ASSISTANCE PERCENTAGES,
EFFECTIVE OCTOBER 1, 2012–SEPTEMBER 30, 2013 (FISCAL YEAR 2013)—Continued
Federal medical
assistance
percentages
State
Kansas .............................................................................................................................................
Kentucky ..........................................................................................................................................
Louisiana ..........................................................................................................................................
Maine ...............................................................................................................................................
Maryland ..........................................................................................................................................
Massachusetts .................................................................................................................................
Michigan ...........................................................................................................................................
Minnesota ........................................................................................................................................
Mississippi ........................................................................................................................................
Missouri ............................................................................................................................................
Montana ...........................................................................................................................................
Nebraska ..........................................................................................................................................
Nevada .............................................................................................................................................
New Hampshire ...............................................................................................................................
New Jersey ......................................................................................................................................
New Mexico .....................................................................................................................................
New York .........................................................................................................................................
North Carolina ..................................................................................................................................
North Dakota ....................................................................................................................................
Northern Mariana Islands* ...............................................................................................................
Ohio .................................................................................................................................................
Oklahoma .........................................................................................................................................
Oregon .............................................................................................................................................
Pennsylvania ....................................................................................................................................
Puerto Rico* .....................................................................................................................................
Rhode Island ....................................................................................................................................
South Carolina .................................................................................................................................
South Dakota ...................................................................................................................................
Tennessee .......................................................................................................................................
Texas ...............................................................................................................................................
Utah .................................................................................................................................................
Vermont ...........................................................................................................................................
Virgin Islands* ..................................................................................................................................
Virginia .............................................................................................................................................
Washington ......................................................................................................................................
West Virginia ....................................................................................................................................
Wisconsin .........................................................................................................................................
Wyoming ..........................................................................................................................................
Enhanced federal
medical assistance
percentages
56.51
70.55
61.24
62.57
50.00
50.00
66.39
50.00
73.43
61.37
66.00
55.76
59.74
50.00
50.00
69.07
50.00
65.51
52.27
55.00
63.58
64.00
62.44
54.28
55.00
51.26
70.43
56.19
66.13
59.30
69.61
56.04
55.00
50.00
50.00
72.04
59.74
50.00
69.56
79.39
72.87
73.80
65.00
65.00
76.47
65.00
81.40
72.96
76.20
69.03
71.82
65.00
65.00
78.35
65.00
75.86
66.59
68.50
74.51
74.80
73.71
68.00
68.50
65.88
79.30
69.33
76.29
71.51
78.73
69.23
68.50
65.00
65.00
80.43
71.82
65.00
* For purposes of section 1118 of the Social Security Act, the percentage used under titles I, X, XIV, and XVI will be 75 per centum.
** The values for the District of Columbia in the table were set for the state plan under titles XIX and XXI and for capitation payments and DSH
allotments under those titles. For other purposes, the percentage for DC is 50.00, unless otherwise specified by law.
TABLE 2—FISCAL YEAR 2013 DISASTER-RECOVERY ADJUSTED FMAP RATES
A
B
C
D
E
F
State
FY13 FMAP
FY12 Disasterrecovery
adjusted FMAP
Difference in
FMAP
Disasterrecovery
adjustment
increase
FY13 Disasterrecovery adjusted
FMAP
25% × Col D
Col C + E
2.14
71.92
Col C–B
Louisiana ................................................
61.24
[FR Doc. 2011–30860 Filed 11–29–11; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ACTION:
Mandatory Guidelines for Federal
Workplace Drug Testing Programs
SUMMARY:
emcdonald on DSK5VPTVN1PROD with NOTICES
BILLING CODE 4150–05–P
69.78
8.54
Substance Abuse and Mental
Health Services Administration
(SAMHSA), Department of Health and
Human Services.
AGENCY:
VerDate Mar<15>2010
17:30 Nov 29, 2011
Jkt 226001
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
HHS Approval of Entities That
Certify Medical Review Officers (MRO).
The current version of the
Department of Health and Human
Services (HHS) Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines),
effective on October 1, 2010, addresses
the role and qualifications of Medical
E:\FR\FM\30NON1.SGM
30NON1
emcdonald on DSK5VPTVN1PROD with NOTICES
74064
Federal Register / Vol. 76, No. 230 / Wednesday, November 30, 2011 / Notices
Review Officers (MROs) and HHS
approval of entities that certify MROs.
Subpart M—Medical Review Officer
(MRO), Section 13.1(b), ‘‘Who may serve
as an MRO?’’ states as follows:
‘‘Nationally recognized entities that
certify MROs or subspecialty boards for
physicians performing a review of
Federal employee drug testing results
that seek approval by the Secretary must
submit their qualifications and a sample
examination. Based on an annual
objective review of the qualifications
and content of the examination, the
Secretary shall publish a list in the
Federal Register of those entities and
boards that have been approved.’’
HHS has completed its review of
entities that train and certify MROs, in
accordance with requests submitted by
such entities to HHS.
(1) The HHS Secretary approves the
following MRO certifying entities that
offer both MRO training and
certification through examination:
American Association of Medical
Review Officers (AAMRO), P.O. Box
12873, Research Triangle Park, NC
27709, Phone: (800) 489–1839, Fax:
(919) 490–1010, Email: cferrell@
aamro.com, Web site: https://www.
aamro.com/.
Medical Review Officer Certification
Council (MROCC), 836 Arlington
Heights Road, #327, Elk Grove
Village, IL 60007, Phone: (847) 631–
0599, Fax: (847) 483–1282, Email:
mrocc@mrocc.org, Web site: https://
www.mrocc.org/.
(2) The HHS Secretary lists the
following entities that offer MRO
training as a prerequisite for MRO
certification:
American College of Occupational and
Environmental Medicine (ACOEM),
25 Northwest Point Boulevard, Suite
700, Elk Grove Village, IL 60007–
1030, Phone: (847) 818–1800, Fax:
(847) 818–9266, Contact Form: https://
www.acoem.org/contactacoem.aspx,
Web site: https://www.acoem.org/.
American Society of Addiction
Medicine (ASAM), 4601 N. Park
Avenue, Upper Arcade #101, Chevy
Chase, MD 20815, Phone: (301) 656–
3920, Fax: (301) 656–3815, Email:
email@asam.org, Web site: https://
www.asam.org/.
DATES: HHS approval is effective
November 30, 2011.
FOR FURTHER INFORMATION CONTACT:
Jennifer Fan, Pharm.D., J.D., Division of
Workplace Programs (DWP), Center for
Substance Abuse Prevention (CSAP),
Substance Abuse and Mental Health
Services Administration (SAMHSA), 1
VerDate Mar<15>2010
17:30 Nov 29, 2011
Jkt 226001
Choke Cherry Road, Room 2–1031,
Rockville, MD 20857; Telephone: (240)
276–1759; Email: jennifer.fan@
samhsa.hhs.gov.
Dated: November 21, 2011.
Kathleen Sebelius,
Secretary.
[FR Doc. 2011–30846 Filed 11–29–11; 8:45 am]
BILLING CODE ;P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–12–0666]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
National Healthcare Safety Network
(NHSN) (OMB No. 0920–0666 exp.
3/31/2012)—Revision—National Center
for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The National Healthcare Safety
Network (NHSN) is a system designed to
accumulate, exchange, and integrate
relevant information and resources
among private and public stakeholders
to support local and national efforts to
protect patients and to promote
healthcare safety. Specifically, the data
is used to determine the magnitude of
various healthcare-associated adverse
events and trends in the rates of these
events among patients and healthcare
workers with similar risks. Healthcare
institutions that participate in NHSN
voluntarily report their data to CDC
using a web browser based technology
for data entry and data management.
Data are collected by trained
surveillance personnel using written
standardized protocols. The data will be
used to detect changes in the
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
epidemiology of adverse events
resulting from new and current medical
therapies and changing risks.
This revision submission includes an
amended Assurance of Confidentiality,
which required an update of the
Assurance of Confidentiality language
on all forms included in the NHSN
surveillance system. The scope of NHSN
dialysis surveillance is being expanded
to include all outpatient dialysis centers
so that the existing Dialysis Annual
Survey can be used to facilitate
prevention objectives set forth in the
HHS HAI tier 2 Action Plan and to
assess national practices in all
Medicare-certified dialysis centers if
CMS re-establishes this survey method
(as expected). The Patient Safety (PS)
Component is being expanded to
include long term care facilities to
facilitate HAI surveillance in this
setting, for which no standardized
reporting methodology or mechanism
currently exists. Four new forms are
proposed for this purpose. A new form
is proposed to be added to the
Healthcare Personnel Safety (HPS)
Component to facilitate summary
reporting of influenza vaccination in
healthcare workers, which is anticipated
to be required by CMS in the near
future. In addition to this new form, the
scope of the HPS Annual Facility
Survey is being expanded to include all
acute care facilities that would enroll if
CMS does implement this requirement.
The NHSN Antimicrobial Use and
Resistance module is transitioning from
manual web entry to electronic data
upload only, which results in a
significant decrease to the reporting
burden for this package. Finally, there
are many updates, clarifications, and
data collection revisions proposed in
this submission.
CDC is requesting to delete four
currently approved forms that are no
longer needed by the NHSN and add
five new forms
The previously-approved NHSN
package included 47 individual data
collection forms. If all proposed
revisions are approved, the reporting
burden will decrease by 1,258,119
hours, for a total estimated burden of
3,914,125 hours and 48 total data
collection tools.
Participating institutions must have a
computer capable of supporting an
Internet service provider (ISP) and
access to an ISP. There is no cost to
respondents other than their time. The
total estimated annual burden hours are
3,914,125.
E:\FR\FM\30NON1.SGM
30NON1
]]>Agencies
[Federal Register Volume 76, Number 230 (Wednesday, November 30, 2011)]
[Notices]
[Pages 74063-74064]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-30846]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Mandatory Guidelines for Federal Workplace Drug Testing Programs
AGENCY: Substance Abuse and Mental Health Services Administration
(SAMHSA), Department of Health and Human Services.
ACTION: HHS Approval of Entities That Certify Medical Review Officers
(MRO).
-----------------------------------------------------------------------
SUMMARY: The current version of the Department of Health and Human
Services (HHS) Mandatory Guidelines for Federal Workplace Drug Testing
Programs (Mandatory Guidelines), effective on October 1, 2010,
addresses the role and qualifications of Medical
[[Page 74064]]
Review Officers (MROs) and HHS approval of entities that certify MROs.
Subpart M--Medical Review Officer (MRO), Section 13.1(b), ``Who may
serve as an MRO?'' states as follows: ``Nationally recognized entities
that certify MROs or subspecialty boards for physicians performing a
review of Federal employee drug testing results that seek approval by
the Secretary must submit their qualifications and a sample
examination. Based on an annual objective review of the qualifications
and content of the examination, the Secretary shall publish a list in
the Federal Register of those entities and boards that have been
approved.''
HHS has completed its review of entities that train and certify
MROs, in accordance with requests submitted by such entities to HHS.
(1) The HHS Secretary approves the following MRO certifying
entities that offer both MRO training and certification through
examination:
American Association of Medical Review Officers (AAMRO), P.O. Box
12873, Research Triangle Park, NC 27709, Phone: (800) 489-1839, Fax:
(919) 490-1010, Email: cferrell@aamro.com, Web site: https://www.aamro.com/.
Medical Review Officer Certification Council (MROCC), 836 Arlington
Heights Road, 327, Elk Grove Village, IL 60007, Phone: (847)
631-0599, Fax: (847) 483-1282, Email: mrocc@mrocc.org, Web site: https://www.mrocc.org/.
(2) The HHS Secretary lists the following entities that offer MRO
training as a prerequisite for MRO certification:
American College of Occupational and Environmental Medicine (ACOEM), 25
Northwest Point Boulevard, Suite 700, Elk Grove Village, IL 60007-1030,
Phone: (847) 818-1800, Fax: (847) 818-9266, Contact Form: https://www.acoem.org/contactacoem.aspx, Web site: https://www.acoem.org/.
American Society of Addiction Medicine (ASAM), 4601 N. Park Avenue,
Upper Arcade 101, Chevy Chase, MD 20815, Phone: (301) 656-
3920, Fax: (301) 656-3815, Email: email@asam.org, Web site: https://www.asam.org/.
DATES: HHS approval is effective November 30, 2011.
FOR FURTHER INFORMATION CONTACT: Jennifer Fan, Pharm.D., J.D., Division
of Workplace Programs (DWP), Center for Substance Abuse Prevention
(CSAP), Substance Abuse and Mental Health Services Administration
(SAMHSA), 1 Choke Cherry Road, Room 2-1031, Rockville, MD 20857;
Telephone: (240) 276-1759; Email: jennifer.fan@samhsa.hhs.gov.
Dated: November 21, 2011.
Kathleen Sebelius,
Secretary.
[FR Doc. 2011-30846 Filed 11-29-11; 8:45 am]
BILLING CODE ;P
